StockData
Bio Key International Inc logo

Bio Key International Inc (BKYI) stock

BKYINasdaqServices-Prepackaged SoftwareFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/3072% below fair value
$2.10+0.11 (+5.53%)

Close on Nov 19, 2026Market cap $3.02MP/E –Yield –

Bio Key International revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Bio Key International's revenue for the twelve months ending Jun 30, 2026 was $6.70M, down 3.1% year over year. For fiscal 2025 it was $5.94M, down 14.3% from the year before. Over ten years it grew 1.2% a year on average. The highest annual figure on record is $7.75M in fiscal 2023.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.94M-14.3%
FY2024Dec 31, 2024$6.93M-10.6%
FY2023Dec 31, 2023$7.75M+10.5%
FY2022Dec 31, 2022$7.02M+37.3%
FY2021Dec 31, 2021$5.11M+80.3%
FY2020Dec 31, 2020$2.84M+25.1%
FY2019Dec 31, 2019$2.27M-43.9%
FY2018Dec 31, 2018$4.04M-35.8%
FY2017Dec 31, 2017$6.30M+111.8%
FY2016Dec 31, 2016$2.98M-43.4%
FY2015Dec 31, 2015$5.26M+31.3%
FY2014Dec 31, 2014$4.01M+101.7%
FY2013Dec 31, 2013$1.99M-48.2%
FY2012Dec 31, 2012$3.84M+9.3%
FY2011Dec 31, 2011$3.51M-0.3%
FY2010Dec 31, 2010$3.52M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.92M+13.1%
Q1 FY2026Mar 31, 2026$2.15M+33.5%
Q4 FY2025Dec 31, 2025$1.08M-25.9%
Q3 FY2025Sep 30, 2025$1.55M-27.7%
Q2 FY2025Jun 30, 2025$1.70M+48.7%
Q1 FY2025Mar 31, 2025$1.61M-26.3%
Q4 FY2024Dec 31, 2024$1.46M-19.9%
Q3 FY2024Sep 30, 2024$2.14M+18.0%
Q2 FY2024Jun 30, 2024$1.14M-40.8%
Q1 FY2024Mar 31, 2024$2.18M-0.1%
Q4 FY2023Dec 31, 2023$1.83M+3.8%
Q3 FY2023Sep 30, 2023$1.82M+32.3%
Q2 FY2023Jun 30, 2023$1.93M-0.9%
Q1 FY2023Mar 31, 2023$2.18M+12.5%
Q4 FY2022Dec 31, 2022$1.76M+88.1%
Q3 FY2022Sep 30, 2022$1.37M+5.8%
Q2 FY2022Jun 30, 2022$1.95M+96.3%
Q1 FY2022Mar 31, 2022$1.94M+2.8%
Q4 FY2021Dec 31, 2021$934.93K-12.1%
Q3 FY2021Sep 30, 2021$1.30M+37.7%
Q2 FY2021Jun 30, 2021$992.09K+223.0%
Q1 FY2021Mar 31, 2021$1.89M+261.5%
Q4 FY2020Dec 31, 2020$1.06M+98.9%
Q3 FY2020Sep 30, 2020$943.33K+108.4%
Q2 FY2020Jun 30, 2020$307.14K-57.8%
Q1 FY2020Mar 31, 2020$522.49K-5.3%
Q4 FY2019Dec 31, 2019$534.81K-68.8%
Q3 FY2019Sep 30, 2019$452.71K-38.8%
Q2 FY2019Jun 30, 2019$728.38K-2.6%
Q1 FY2019Mar 31, 2019$551.62K-34.4%
Q4 FY2018Dec 31, 2018$1.72M-43.9%
Q3 FY2018Sep 30, 2018$739.75K-21.5%
Q2 FY2018Jun 30, 2018$748.14K-15.6%
Q1 FY2018Mar 31, 2018$841.46K-40.7%
Q4 FY2017Dec 31, 2017$3.06M+80.0%
Q3 FY2017Sep 30, 2017$942.42K+118.4%
Q2 FY2017Jun 30, 2017$886.88K–
Q1 FY2017Mar 31, 2017$1.42M–
Q4 FY2016Dec 31, 2016$1.70M–
Q3 FY2016Sep 30, 2016$431.46K–

More Bio Key International figures

See a number that looks wrong?